Reduces 40% more subcutaneous fat in a third of the time.
The first device in the world to reduce visceral fat by 4% in less than two weeks (12 days).
Strengthens muscles and tightens the skin.
Reduces appetite (scientifically proven through the statistically significant reduction of the leptin hormone in the blood).
With scientific evidence shown by MRI scan.
This technology has clinically shown to offer an average 20% reduction of the subcutaneous fat and can be adapted to each individual’s necessities.
After treatment with DRAKARIAN®, an average of 830 grams was lost, of which 6 grams are subcutaneous fat, as measured by MRI. This reduction of subcutaneous fat is statistically significant. The average reduction of this fat in patients participating in the study is of 20%. It visibly improves the patients’ aesthetical appearance.
After applying the device and performing the MRI, not only is a reduction of the subcutaneous fat appreciated, but a reduction of the visceral fat as well. The average reduction in 12 days is of 15%.
In short, DRAKARIAN® reduces subcutaneous fat by 20% in 12 days, boosting the patient’s aesthetic improvement, and reduces visceral fat by an average 12% in 12 days, improving the patient’s cardiovascular health in general. This means we can improve the metabolic disorders of obese patients.
Certain authors suggest that a subcutaneous CAT scan of the abdominal area is the best test to determin the plasmatic insulin and triglyceride levels. In spite of many authors signaling visceral fat as the most important fat type, there are other authors who state that the relation Visceral fat / Subcutaneous fat is a good predictor of metabolic discorders.
Capenergy Medical. All rights reserved